Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Adv Drug Deliv Rev. 2012 Oct 1;65(1):80–88. doi: 10.1016/j.addr.2012.09.038

Figure 1.

Figure 1

Nanomedicine publication profiles over time. A: Polymeric cancer therapeutics, B: liposomal cancer therapeutics and C: monoclonal antibody therapeutics. Solid line: Number of publications per year, Dashed line: number of citations per year and Dotted line: number of published clinical trials per year.

HHS Vulnerability Disclosure